Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 406-850-2 | CAS number: 133855-98-8 BAS 480 F
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- (1981)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- (2RS,3RS)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
- EC Number:
- 406-850-2
- EC Name:
- (2RS,3RS)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
- Cas Number:
- 133855-98-8
- Molecular formula:
- C17 H13 Cl F N3 O
- IUPAC Name:
- 1-{[(2R,3R)-3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr. K. Thomae GmbH, Biberach
- Mean weight at study initiation: 200g males, 192 g females
- Housing: In groups of 5 in steel wire mess cages Type DK-III
- Diet ad libitum: Kliba diet 343
- Water ad libitum: Tap water
- Acclimation period: 1 week
-Fasting period: Animals were withdrawn from food 16 h before administration
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20- 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- 0.5 % aqueous solution
- Details on oral exposure:
- DOSE VOLUME APPLIED: 10 ml/kg bw
- Doses:
- 5000, 3160 and 1470 mg/kg bw
- No. of animals per sex per dose:
- 5 males and 5 females per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 21 days
- Necropsy of survivors performed: yes/no
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other:
- Duration of observation period following administration: 21 days
- Frequency of observations for clinical symptoms: Several times on first day, afterwards once each workday.
- Frequency of observations for mortality: Several times on first day, afterwards twice on workday and once on holidays.
- Frequency of weighing: On first day, day 7, day 13 and day 20.
- Necropsy of survivors performed: Yes, at study termination all animals were sacrificed and subjected to gross pathology. Moribund animals were examined as early as possible.
Results and discussion
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 1/5 females was found dead at the highest dose group (5000 mg/kg bw)
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 3 160 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 2/5 males were found dead at the highest and the mid dose group (5000 and 3160 mg/kg bw).
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 3/10 animals were found dead at the highest and 2/10 animals were found dead at the mid dose group (5000 and 3160 mg/kg bw, respectively).
- Mortality:
- 1/5 females and 2/5 males were found dead at the highest dose group (5000 mg/kg bw).
0/5 females and 2/5 males were found dead at the mid dose group (3160 mg/kg bw).
No animal died at the lowest dose group (1470 mg/kg bw). - Clinical signs:
- other: Clinical symptoms, like dyspnea, imbalance, excitation, staggering, spastic gait, piloerection, alopecia and a poor general state were seen in animals of both sexes at 5000 and 3160 mg/kg bw.
- Gross pathology:
- Animals that died:
In males that died, necropsy revealed general congestion at 3160 and 5000 mg/kg bw. In addition, the liver of males treated with 5000 mg/kg bw showed a yellow-brown tinge. The examination of 1 dead male at 3160 mg/kg bw and of 1 dead female at 5000 mg/kg bw was not possible due to decomposition.
Animals that were sacrificed at test ending:
No macroscopic findings were observed in animals sacrificed at study termination.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The oral median lethal dose of the test substance in rats is higher than 5000 mg/kg bw.
- Executive summary:
The substance was tested for its potential acute hazard after single oral administration. The test method was based on EPA (FIFRA) and OECD 401 guidelines. GLP requirements were fulfilled. 5 male and 5 female Wistar rats per dose group were administered 1470, 3160 and 5000 mg/kg bw of the test substance by gavage. The observation period was 14 days. Unspecific clinical symptoms occurred in the two high dose group. Mortality occurred in the dosages of 3160 and 5000 mg/kg bw.
Necropsy findings in animals that died were: general congestion, yellow brown tinge of the liver. Thus, the LD50 (oral) in rats is > 5000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.